Market Insights Snapshot
In the realm of Tincture & Sublingual category, Chronic Health has shown consistent performance in Arizona, maintaining the 2nd position from July to October 2023. Despite a slight decrease in sales from July to August, the brand managed to rebound and maintain a stable sales volume for the remaining months. This suggests a strong and steady demand for Chronic Health's products in this category within the Arizona market.
When it comes to the Topical category, Chronic Health exhibited a dynamic performance in Arizona. The brand started off strong in July 2023, ranking 1st in the category. However, it experienced a slight dip in August and September, sliding to the 2nd and 3rd positions respectively. Despite this, Chronic Health managed to bounce back to the 2nd position in October. Interestingly, even with the fluctuation in ranking, the brand saw a significant increase in sales in October compared to the previous months, indicating a potential upward trend in the popularity of their topical products.
In the Topical category in Arizona, Chronic Health has seen a fluctuation in its ranking over the months of July to October 2023. Initially leading the pack in July, it slipped to second place in August and further to third in September, before bouncing back to second position in October. This indicates a highly competitive market, with brands like iLava and Müv / MUV consistently vying for the top spots. Interestingly, while iLava dropped from first to third place in October, Müv / MUV climbed to the top spot, indicating a potential shift in consumer preference. Meanwhile, Drip Oils + Extracts has maintained a steady fourth position. Despite the rank fluctuations, Chronic Health's sales have shown an upward trend from August to October, suggesting a growing customer base or increased product demand.
In October 2023, the top-performing product for Chronic Health was the CBD/THC 1:1 Pain Relief Ointment (175mg CBD, 175mg THC), maintaining its position as the top seller from the previous month. The CBD/THC 1:1 Glycerin Tincture (200mg CBD, 200mg THC, 30ml) moved up three ranks to secure the second position. The third best-selling product was the CBD/THC 1:1 Pain Releaf Ointment (350mg CBD, 350mg THC, 4oz), which was not in the top five in September 2023. The fourth spot was taken by the CBD/THC 1:1 Glycerin Tincture (100mg CBD, 100mg THC, 0.5oz), dropping three places from its first-place position in September. The CBD/THC 1:1 Pain ReLief Ointment (40mg CBD, 40mg THC) made its debut in the top five, securing the fifth position with sales figures reaching 162 units.